US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

55.04

+1.102.03%

Post-market: 55.040.00000.00%19:30 EDT

Volume:33.64K

Turnover:1.85M

Market Cap:192.64M

PE:- -

High:55.51

Open:54.50

Low:54.37

Close:53.95

52wk High:70.85

52wk Low:40.40

Shares:3.50M

Float Shares:3.50M

Volume Ratio:0.55

T/O Rate:0.96%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics

MT Newswires Live

Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger

Abbvie Completes Acquisition of Apogee Therapeutics

THOMSON REUTERS

Abbvie - Reaffirms 2026 Q3 Adj Diluted EPS Guidance $3.84-$3.88

THOMSON REUTERS

NASDAQ Trade Halt Trading Halted; for Information Requested by NASDAQ at 07:50 Pm

CG Oncology CEO Joins Cantor Fitzgerald Global Healthcare Conference Fireside Chat

CG Oncology to Present at Upcoming Investor Conferences in September

Xenon CMO Christopher John Kenney Reports Disposal of Common Shares Worth $425,469.33

Xenon Grants 13,450 Inducement Stock Options, 7,850 RSUs to New Hires at $61.93 Strike

Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half

Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?

Simply Wall St.

Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital

AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal

CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/SBIO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":55.04,"timestamp":1791576000000,"preClose":53.945,"halted":0,"volume":33639,"hourTrading":{"tag":"盘后","latestPrice":55.04,"preClose":55.04,"latestTime":"19:30 EDT","volume":20,"amount":1097.9053,"timestamp":1791588605643,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.020298452127166536,"floatShares":3500000,"shares":3500000,"eps":0,"marketStatus":"Market Closed","change":1.095,"latestTime":"10-09 16:00:00 EDT","open":54.5,"high":55.5141,"low":54.365,"amount":1850295.02994,"amplitude":0.021301,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":53.945,"sharesOutstanding":2675000,"nav":53.95,"aum":187460316.33,"bidAskSpread":0.002399,"postHourTrading":{"tag":"盘后","latestPrice":55.04,"preClose":55.04,"latestTime":"19:30 EDT","volume":20,"amount":1097.9053,"timestamp":1791588605643,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.547086,"impliedVol":0.3943,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3500000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.547086,"shares":3500000,"dividePrice":0,"high":55.5141,"amplitude":0.021301,"preClose":53.945,"low":54.365,"week52Low":40.4,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":55.04,"eps":0,"divideRate":0,"volume":33639,"delay":0,"ttmEps":0,"open":54.5,"prevYearClose":51.22,"prevWeekClose":56.15,"prevMonthClose":58.3,"prevQuarterClose":58.3,"fiveDayClose":56.15,"twentyDayClose":63.29,"sixtyDayClose":63.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZNH","PBE","FHLC","SURI","PINK","RSPH","PBPH","APXH","IDNA","BIB","HRTS","GNMX","IBBJ","IBRN","NVIB","HYLG","GSKH","GPCR","BBH","PSIL","XPH","PJP","MDTX","MEDI","JDOC","CNCR","FBT","LLYX","FXH","JHMH","WDNA","SYNB","FTXH","MNTL","MEDX","PSCH","LENZ","CURE","GDOC","IBB","MRNY","BBP","GNOM","LFSC","TBXU","PTH","SBIO","IBBQ","CANC","BME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127014248","title":"AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1127014248","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127014248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:44","pubTimestamp":1788486257,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE: ABBV) announced on Thursday that it has finalized its $10.9 billion acquisition of inflammation drug developer Apogee Therapeutics (NASDAQ: APGE). This transaction marks the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0053671581.USD","LU2089984988.USD","BK4139","PPH","LU2237443978.SGD","BK4534","IE00BJT1NW94.SGD","LU0795875169.SGD","LU1551013425.SGD","IE00BFTCPJ56.SGD","IE0002270589.USD","MEDX","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1244550494.USD","LU0069063385.USD","SG9999015986.USD","IYH","IE000BZT7R73.USD","IE00BDGV0183.EUR","LU1496350171.SGD","LU2347655073.USD","LU2112291526.USD","LU2089284900.SGD","LU0289739343.SGD","LU0122379950.USD","BK4533","LU0211328371.USD","LU0114720955.EUR","LU0310799852.SGD","LU1989772923.USD","IE000F7OJYX1.SGD","LU2089283258.USD","LU0203345920.USD","LU1244550221.USD","LU0211327993.USD","LU0689626769.HKD","MYLD","BK4588","LU0882574055.USD","LU0861579265.USD","IE0000B7K699.USD","LU0949170772.SGD","LU0098860793.USD","IXJ","LU2129689514.USD","LU2129689605.HKD","LU0820561818.USD","LU0738911758.USD","BK4550","LU2433249047.HKD","LU1983299246.USD","LU0395794307.EUR","SG9999001440.SGD","SG9999003800.SGD","LU0256863902.USD","LU0965509283.SGD","LU1670628061.USD","LU1934455194.USD","SBIO","LU2129689431.USD","IE00BVYPNV92.GBP","LU1236620834.HKD","APGE","KCE","LU1732799900.SGD","LU1839511570.USD","LU0472753341.HKD","LU2125909247.SGD","LU0289739699.SGD","IE000MB6IJN5.SGD","LU0942090050.USD","LU1093756325.SGD","LU0256863811.USD","LU1023059063.AUD","LU0058720904.USD","BK4585","LU0198837287.USD","LU0432979614.USD","LU2237443382.USD","IE00B3PB1722.GBP","LU2237443465.HKD","LU0689472784.USD","IE00BBT3K403.USD","IE00BN8TJ469.HKD","LU0057025933.USD","LU1236620750.USD","LU0203347892.USD","LU0985320562.USD","LU1162221912.USD","IE00B2B36J28.USD","LU0859254822.USD","LU2023251221.USD","LU0820561909.HKD","LU2087621335.USD","LU0417517546.SGD","BK4566","LU0029864427.USD","XMMO","BK4559","VHT","LU0868494708.USD","LU1670627923.USD","LU0868494617.USD","AGNG","LU1061106388.HKD","FHLC","TRUH","IE00BLSP4239.USD","LU0158827948.USD","LU1585245621.USD","LU0320765646.SGD","LU2237443622.USD","LU1074936037.SGD","LU0965509101.SGD","LU2125909593.SGD","GLAM","LU0943347566.SGD","LU2468319806.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU1732800096.USD","LU0545039389.USD","IE00B19Z3581.USD","IE000WAW04H5.SGD","IE0002141913.USD","PJP","LU1496350502.SGD","LU0726765562.USD","LU0795875086.SGD","IE0009355771.USD","SG9999015978.USD","IE00BVYPNW00.USD","LU1037948541.HKD","LU0553294199.USD","LU0456855351.SGD","LU0823416689.USD","LU0912757837.SGD","LU1057294990.SGD","LU1923622614.USD","LU2133065610.SGD","CALF","LU0708994859.HKD","LU1989771016.USD","LU1037948897.HKD","XLV","LU1093756168.USD","LU1244550577.SGD","LU1430594728.SGD","IE0004445239.USD","LU1003077747.HKD","LU0128525929.USD","LU2347655156.SGD","LU1718418525.SGD","LU0170899867.USD","LU1291159041.SGD","LU0511384066.AUD","LU2237443549.SGD","SG9999015945.SGD","LU0965508806.USD","LU1934455277.USD","BK4581","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0124676726.USD","JDOC","RXL","IE00BLSP4452.SGD","LU0965509010.AUD","IE00B42XCP33.USD","LU2357627491.SGD","LU0661504455.SGD","ABBV","LU1989772840.SGD","LU0289961442.SGD","LU1929549753.HKD","LU1934455863.HKD","LU2237443895.HKD","IE00BGHQF631.EUR","IE000SO60NU8.SGD","LU1267930490.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","FTXH","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VHT","LU1496350171.SGD","HCM","LABU","HCSG","LU0029864427.USD","LU0553294199.USD","LU0256863811.USD","FTXH","LU2125909593.SGD","AGNG","PJP","IE0004445239.USD","RXL","LU0708994859.HKD","IXJ","LU1244550577.SGD","LU0128525929.USD","LU0289961442.SGD","PPH","LU1989772923.USD","IBB","IE00B4R5TH58.HKD","ABBV","BK4137","IYH","LU0124676726.USD","LU0114720955.EUR","LU0203345920.USD","GSKH","LU2237443382.USD","LU1718418525.SGD","MEDX","XBI","LU0820561909.HKD","BK4534","RARE","SBIO","LU1236620750.USD","IE00BGHQF631.EUR","LU0432979614.USD","GLAM","GSK","JDOC","IE00BJJMRZ35.SGD","APGE","XLV","TRUH","GSK.UK","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720938","title":"AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720938","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:13","pubTimestamp":1788441193,"startTime":"0","endTime":"0","summary":"AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share.The acquisition is expected to negatively impact adjusted diluted earnings per share by $0.14 in 2026 and by approximately $0.46 in 2027, with accretion beginning in 2032, AbbVie said.Apogee Therapeutics' stock ceased trading on the Nasdaq stock exchange prior to the market open on Sept. 3, according to a statement.AbbVie said it continues to expect Q3 adjusted diluted EPS in the range of $3.84 to $3.88, and full-year adjusted diluted EPS between $13.87 to $14.07.Analysts polled by FactSet expect $3.86 and $14.03, respectively.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0069063385.USD","LU1093756325.SGD","LU0456855351.SGD","LU0949170772.SGD","AGNG","LU0310799852.SGD","PPH","LU0738911758.USD","GLAM","LU0965509010.AUD","LU0985320562.USD","RXL","ABBV","LU1244550494.USD","IYH","LU0320765646.SGD","TRUH","LU2129689514.USD","LU1923622614.USD","MEDX","LU1037948897.HKD","FHLC","IXJ","LU0417517546.SGD","SG9999011175.SGD","LU2237443622.USD","PJP","VHT","XLV","LU0289961442.SGD","LU0432979614.USD","APGE","SBIO","IE00BVYPNV92.GBP","JDOC","LU0057025933.USD","LU2089283258.USD","LU0795875169.SGD","LU1267930573.SGD","LU0289739343.SGD","LU0965509101.SGD","LU2125909247.SGD","LU0795875086.SGD","LU2237443382.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1061106388.HKD","IE00B19Z3B42.SGD","FTXH","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872503","title":"Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872503","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:54","pubTimestamp":1788440071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie mergerApogee notified Nasdaq of its merger close, requesting delisting and continued trading halt; shares suspended from trading Sept. 4, 2026.Nasdaq to file SEC Form 25 to delist and deregister the stock under Exchange Act Section 12.Company plans to file SEC Form 15 to terminate registration under Section 12, suspending reporting obligations under Sections 13 and 15.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3D254h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","PPH","IE000MB6IJN5.SGD","SBIO","LU1061106388.HKD","LU2112291526.USD","LU2468319806.SGD","JDOC","AGNG","LU2347655073.USD","MEDX","IE00B4R5TH58.HKD","LU2237443549.SGD","IE00BJJMRZ35.SGD","RXL","LU0320765646.SGD","LU1989771016.USD","LU0820561909.HKD","LU2237443382.USD","VHT","IXJ","SG9999003800.SGD","LU1670627923.USD","LU0985320562.USD","IE00BN8TJ469.HKD","FHLC","FTXH","TRUH","LU0868494708.USD","ABBV","LU2133065610.SGD","LU0882574055.USD","IE000F7OJYX1.SGD","IE00B3PB1722.GBP","IYH","LU2089284900.SGD","GLAM","LU1023059063.AUD","XLV","BK4534","LU0965509010.AUD","LU1934455277.USD","LU2237443895.HKD","LU0128525929.USD","PJP","LU0943347566.SGD","LU0965508806.USD","APGE","LU2129689514.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874750","title":"Abbvie Completes Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874750?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","JDOC","LU0057025933.USD","GLAM","LU0158827948.USD","IE000MB6IJN5.SGD","LU0912757837.SGD","LU0234570918.USD","LU0098860793.USD","APGE","IXJ","LU1291159041.SGD","BK4139","AGNG","TRUH","LU1496350171.SGD","LU1989772840.SGD","ABBV","IYH","LU0726765562.USD","LU2237443465.HKD","PJP","RXL","VHT","LU1839511570.USD","BK4581","IE00B19Z3581.USD","SBIO","SG9999015978.USD","PPH","SG9999011175.SGD","LU2089283258.USD","LU1037948541.HKD","LU2237443978.SGD","LU2087621335.USD","FTXH","LU2112291526.USD","XLV","LU0289739343.SGD","BK4559","IE0002141913.USD","BK4566","IE000F7OJYX1.SGD","LU0795875086.SGD","LU1934455863.HKD","LU0511384066.AUD","LU0985320562.USD","IE0004445239.USD","LU0820561818.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787475","title":"Abbvie - Reaffirms 2026 Q3 Adj Diluted EPS Guidance $3.84-$3.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1057294990.SGD","BK4534","LU0456855351.SGD","SG9999015952.SGD","IE00BJJMRZ35.SGD","LU2023251221.USD","LU0511384066.AUD","LU0053671581.USD","LU1551013342.USD","SBIO","GLAM","BK4585","VHT","LU0114720955.EUR","LU0128525929.USD","LU1934455194.USD","LU1670627923.USD","ABBV","LU1983299246.USD","BK4581","IYH","LU0726765562.USD","LU0689626769.HKD","LU1718418525.SGD","LU1929549753.HKD","RXL","TRUH","APGE","JDOC","MEDX","LU0234572021.USD","LU1003077747.HKD","LU0029864427.USD","LU0203347892.USD","XLV","IE00B3PB1722.GBP","LU0965508806.USD","LU0965509101.SGD","LU1244550494.USD","LU2087621335.USD","BK4588","AGNG","LU0098860793.USD","IE00BBT3K403.USD","PPH","PJP","IXJ","FTXH","FHLC","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664421938","title":"NASDAQ Trade Halt Trading Halted; for Information Requested by NASDAQ at 07:50 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2664421938","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664421938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:50","pubTimestamp":1788393000,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTTRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAQN2MHUGD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","SBIO","BK4139","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664733819","title":"CG Oncology CEO Joins Cantor Fitzgerald Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664733819","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664733819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:05","pubTimestamp":1788350700,"startTime":"0","endTime":"0","summary":"CG Oncology CEO joins Cantor Fitzgerald Global Healthcare Conference fireside chatCG Oncology will join investor conference fireside chats in New York City on Sept. 9, 2026, Sept. 14, 2026.Chairman, P","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL79SQcv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","BCDF","LU0320765646.SGD","LU1989772923.USD","BK4127","NDAQ","LU0528227936.USD","LU2089283258.USD","KBWB","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4504","LU2210150020.SGD","LU0795875169.SGD","IE00BN0W2T93.GBP","LU1732799900.SGD","LU0557290698.USD","LU1244550221.USD","IAI","BK4516","LU2487616109.SGD","BK4581","LU0158827948.USD","LU1162221912.USD","LU2023251221.USD","SG9999014039.USD","LU0971096721.USD","LU2089284900.SGD","LU1720051017.SGD","IE00BQXX3D17.EUR","LU2264538146.SGD","BK4585","BK4588","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU0106261372.USD","LU1988902786.USD","LU0158827781.USD","IE00BGHQF748.EUR","BK4534","LU1989772840.SGD","CGON","SG9999014013.SGD","IE00BQXX3C00.GBP","SBIO","LU2133065610.SGD","IE00B3S45H60.SGD","BK4112","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811865","title":"CG Oncology to Present at Upcoming Investor Conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811865","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811865?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"DALLAS, Sept.  02, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman, President & Chief Executive Officer, will participate in fireside chat presenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355052/0/en/cg-oncology-to-present-at-upcoming-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1988902786.USD","IE00B3S45H60.SGD","LU0390134368.USD","LU1668664300.SGD","IE00BZ1G4Q59.USD","LU0225283273.USD","LU0314104364.USD","BK4516","LU1244550221.USD","LU0795875169.SGD","BK4585","LU1732799900.SGD","LU0971096721.USD","LU0557290698.USD","BK4139","BK4127","CGON","LU1732800096.USD","LU0912757837.SGD","LU2133065610.SGD","LU1244550494.USD","IE00B775SV38.USD","LU0528227936.USD","LU2089284900.SGD","LU2271345857.HKD","IAI","LU0320765646.SGD","LU1074936037.SGD","LU0882574139.USD","KBWB","BK4504","BK4581","LU1791710582.SGD","LU0795875086.SGD","LU1363072403.SGD","LU1720051017.SGD","BK4534","BK4588","LU0106261372.USD","LU0106831901.USD","LU2089283258.USD","LU2028103732.USD","SBIO","LU2357305700.SGD","LU2324357040.USD","LU0006306889.USD","IE00BKVL7J92.USD","LU2111349929.HKD","LU0158827948.USD","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664652882","title":"Xenon CMO Christopher John Kenney Reports Disposal of Common Shares Worth $425,469.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2664652882","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664652882?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:00","pubTimestamp":1788228028,"startTime":"0","endTime":"0","summary":"Xenon CMO Christopher John Kenney reports disposal of common shares worth $425,469.33Xenon Pharmaceuticals Chief Medical Officer Christopher John Kenney sold 7,068 common shares on Aug. 28, 2026.Share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL175Sqs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Xenon CMO Christopher John Kenney Reports Disposal of Common Shares Worth $425,469.33","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","BK4139","XENE","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013901","title":"Xenon Grants 13,450 Inducement Stock Options, 7,850 RSUs to New Hires at $61.93 Strike","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013901","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013901?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:01","pubTimestamp":1787947270,"startTime":"0","endTime":"0","summary":"Xenon grants 13,450 inducement stock options, 7,850 RSUs to new hires at $61.93 strikeXenon Pharmaceuticals granted inducement equity awards to five new non-officer employees, totaling 13,450 share op","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDLbrG4sS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B3QW5Z07.USD","NDAQ","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014005.SGD","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","XENE","LU2095319765.USD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4585","BK4588","IE00B64PRP62.GBP","IE00BQXX3F31.USD","BK4139","SG9999014021.USD","IBRN","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","SBIO","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013922","title":"Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013922","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013922?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:01","pubTimestamp":1787947260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA9GT9VC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XENE","SBIO","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013769","title":"Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013769","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013769?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:01","pubTimestamp":1787947260,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC and BOSTON, MA, Aug.  28, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical devel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/28/3352881/33485/en/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","XENE","SBIO","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476707","title":"Sabio Boosts Margins and Programmatic Growth Ahead of Election-Driven Second Half","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476707?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:32","pubTimestamp":1787178771,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has issued an update. Sabio reported consolidated gross revenues of $9.7 million in the second quarter of 2026, with...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-boosts-margins-and-programmatic-growth-ahead-of-election-driven-second-half?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660520417","title":"Should Xenon’s Wider Q2 Losses to Fund Neurology Pipeline Require Action From Xenon (XENE) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660520417","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660520417?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:51","pubTimestamp":1787115071,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc. recently reported second-quarter 2026 results, with net loss rising to US$110.74 million and basic loss per share from continuing operations at US$1.11, alongside a six‑month net loss of US$213.04 million and basic loss per share of US$2.28.\nThe widening losses compared with the same periods in 2025 give investors fresh insight into how Xenon is funding its ion-channel neurology pipeline ahead of key clinical and commercial milestones.\nWe will now examine how...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/should-xenons-wider-q2-losses-to-fund-neurology-pipeline-req","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","IBRN","BK4139","XENE","SBIO","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660411328","title":"Sabio Secures US$1.5 Million High-Interest Term Loan to Support Working Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2660411328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660411328?lang=en_us&edition=fundamental","pubTime":"2026-08-19 11:02","pubTimestamp":1787108540,"startTime":"0","endTime":"0","summary":"Sabio Holdings ( ($TSE:SBIO) ) has shared an announcement. Sabio Holdings has secured a US$1.5 million non-revolving term loan facility through its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sabio-secures-us1-5-million-high-interest-term-loan-to-support-working-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492377","title":"AbbVie Closes USD 10B Multi-Tranche Senior Notes Offering to Fund Apogee Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492377?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085094,"startTime":"0","endTime":"0","summary":"AbbVie closes USD 10B multi-tranche senior notes offering to fund Apogee dealAbbVie completed a USD 10 billion senior notes offering, including senior floating rate notes due 2028.Deal included fixed-rate senior notes across eight maturities from 2028 to 2066, with coupons from 4.5% to 6.1%.Proceeds earmarked to fund part of the cash consideration for AbbVie’s planned acquisition of Apogee Therapeutics.If the Apogee deal is terminated, AbbVie must redeem the floating-rate notes and fixed-rate notes due 2028-2038 at 101%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbzVC04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","BK4534","IE00B4R5TH58.HKD","LU2129689605.HKD","LU1839511570.USD","LU0395794307.EUR","LU0417517546.SGD","LU0234572021.USD","LU0256863811.USD","LU0310799852.SGD","JDOC","LU0965508806.USD","LU1718418525.SGD","IXJ","LU0708994859.HKD","MEDX","LU0795875086.SGD","LU2125909593.SGD","RXL","ABBV","LU1989771016.USD","LU0114720955.EUR","LU0203347892.USD","TRUH","IYH","IE00BSNM7G36.USD","IE000BZT7R73.USD","AGNG","LU1093756325.SGD","APGE","LU2237443622.USD","LU0128525929.USD","XLV","LU2433249047.HKD","LU0965509283.SGD","IE00B19Z3581.USD","PPH","PJP","LU2237443549.SGD","FTXH","LU0472753341.HKD","BK4533","FHLC","LU0553294199.USD","VHT","SBIO","LU0211328371.USD","IE000SO60NU8.SGD","GLAM","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492308","title":"CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492308","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492308?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:31","pubTimestamp":1787085070,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard Post disposes of USD 74,540 in common sharesCG Oncology director Leonard E. Post sold 1,000 common shares at USD 74.54 on Aug. 14, 2026.The sale followed the exercise of 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL77wBqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGON","SBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLVI","IBB","BK0188","SBIO","601881","GDOC","WRND","BK4585","BK1147","BK1564","06881","BBP","BIOY","APXH","BK4588","161027","LFSC","BK0276","PBE","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":124,"code":"91000000","status":"200"}]}}